As of 2024-12-12, the Relative Valuation of Immunovia AB (publ) (IMMNOV.ST) is (12.90) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 0.72 SEK, the upside of Immunovia AB (publ) based on Relative Valuation is -1888.8%.
The range of the Relative Valuation is (12.48) - (13.74) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 21.8x | 19.6x |
| Forward P/E multiples | 17.5x - 20.1x | 18.0x |
| Fair Price | (12.48) - (13.74) | (12.90) |
| Upside | -1830.9% - -2005.6% | -1888.8% |
| Date | P/E |
| 2024-12-11 | -1.05 |
| 2024-12-10 | -1.11 |
| 2024-12-09 | -1.24 |
| 2024-12-06 | -1.18 |
| 2024-12-05 | -1.17 |
| 2024-12-04 | -1.20 |
| 2024-12-03 | -1.23 |
| 2024-12-02 | -1.28 |
| 2024-11-29 | -1.24 |
| 2024-11-28 | -0.95 |
| 2024-11-27 | -0.90 |
| 2024-11-26 | -0.92 |
| 2024-11-25 | -0.91 |
| 2024-11-22 | -0.87 |
| 2024-11-21 | -0.85 |
| 2024-11-20 | -0.86 |
| 2024-11-19 | -0.84 |
| 2024-11-18 | -0.88 |
| 2024-11-15 | -0.88 |
| 2024-11-14 | -0.90 |
| 2024-11-13 | -0.89 |
| 2024-11-12 | -0.92 |
| 2024-11-11 | -0.97 |
| 2024-11-08 | -0.91 |
| 2024-11-07 | -0.91 |
| 2024-11-06 | -0.87 |
| 2024-11-05 | -0.90 |
| 2024-11-04 | -0.92 |
| 2024-11-01 | -0.89 |
| 2024-10-31 | -0.86 |
| 2024-10-30 | -0.89 |
| 2024-10-29 | -0.91 |
| 2024-10-28 | -0.94 |
| 2024-10-25 | -0.95 |
| 2024-10-24 | -0.96 |
| 2024-10-23 | -0.99 |
| 2024-10-22 | -1.01 |
| 2024-10-21 | -0.94 |
| 2024-10-18 | -0.92 |
| 2024-10-17 | -0.92 |
| 2024-10-16 | -0.93 |
| 2024-10-15 | -0.92 |
| 2024-10-14 | -0.94 |
| 2024-10-11 | -0.96 |
| 2024-10-10 | -0.93 |
| 2024-10-09 | -0.96 |
| 2024-10-08 | -0.97 |
| 2024-10-07 | -1.11 |
| 2024-10-04 | -0.85 |
| 2024-10-03 | -0.87 |